Published • loading... • Updated
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Summary by PR Newswire
8 Articles
8 Articles
PR Newswire+6 Reposted by 6 other sources
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
/PRNewswire/ -- Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd....
·Chicago, United States
Read Full Article
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month - Business News Week
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal’s dedicated sterile injectable facility in Lexington, Kentucky. This partnership addresses ongoing cyclophosphamide shortages and supply chain risks, safeguarding access to this critical medicine for patients across […] The post Piramal Pharma Solution…
Coverage Details
Total News Sources8
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
